Debiopharm, Sigma-Tau Acute Heart Failure Candidate Delivers Strong Phase IIa
This article was originally published in The Pink Sheet Daily
Executive Summary
First-in-class luso-inotropic agent improved systolic and diastolic functions in patients with decompensated heart failure.